Genetics of Appendix Cancer Study

Launched by ANDREANA HOLOWATYJ, PHD, MSCI · Feb 8, 2023

Keywords

ClinConnect Summary

The Genetics of Appendix Cancer Study, also known as the GAP Study, is researching how genetic differences might play a role in the development of appendix cancer. This study is open to adults aged 18 and older who have been diagnosed with various types of appendix cancer, including mucinous neoplasm and adenocarcinoma. The goal is to better understand these cancers and how they may be affected by genetics.

To participate, you need to have a confirmed diagnosis of appendix cancer and be able to provide informed consent. If you are a biological parent of someone currently in the study, you can also take part. The study is not open to pregnant women, prisoners, or individuals who cannot understand the study materials in English. Participants can expect to share their medical history and possibly provide genetic samples, contributing valuable information to help researchers learn more about appendix cancer. Your involvement could help improve care and treatment for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • GAP Social
• • Known diagnosis of appendix cancer in the United States
• • Mentally and physically able to consent and participate in the study
• • GAP Vanderbilt
• • Known diagnosis of appendix cancer
• • Diagnosed by and/or consulting with a physician/clinical provider participating in the GAP Study
• • Mentally and physically able to consent and participate in the study
• • GAP Parent
• • Biological parents (mother and/or father) of individuals actively participating in the GAP Study
• • Residing in the United States
• • Mentally and physically able to consent and participate in the study
• Exclusion Criteria:
• • Women pregnant at the time of consent
• • Prisoners
• • Unable to provide informed consent
• • Unable to read, write, or complete questionnaires in English